A Translational and Neurocomputational Evaluation of a D1R Partial Agonist for Schizophrenia

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: related psychotic disorders | schizophrenia | schizoaffective disorder
  • Age: Between 18 - 45 Years
  • Gender: Male or Female

Other eligibility criteria:

To be eligible, study participants must be 18-45 years old, meet DSM-5 criteria for a primary non-affective psychotic disorder (schizophrenia, schizoaffective, or schizophreniform) with onset of psychosis within the past 5 years. Psychiatric symptoms and treatment must be stable (no active/remarkable SI/HI, no anticipated need to change medications during study).  Patients must not have had an active moderate/severe substance use disorder (except nicotine).  Patients may be unmedicated, but only certain antipsychotics are allowed (olanzapine, clozapine, ziprasidone or asenapine are exclusionary), and certain other psychoactive medications are not allowed (stimulants or other current pharmacotherapy for ADHD, medical cannabis, anticonvulsants except when used as mood stabilizers).

Recruitment Status


Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

If you need assistance finding a non-cancer study or if you have any questions, please email psom-ocr@pobox.upenn.edu